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Drug misuse has significant impacts on families and 
communities and is a major concern for Australia. The 
misuse of licit drugs (such as alcohol and tobacco) continues 
to have the most significant negative impacts, but the use of 
illicit drugs is also a contributing factor in ill-health, injuries, 
violence and criminal behaviour, workplace problems and 
the disruption of family, community and the broader society 
[1]. For categories and definitions of illicit drugs: view http://
www.healthinfonet.ecu.edu.au/illicit_review/info
The greater level of substance misuse in the Indigenous 
population reflects the history of dispossession and 
oppression of Indigenous people; their entrenched social 
and economic marginalisation requires holistic and 
well-funded strategies to address the underlying social 
determinants of Indigenous ill-health [2].
General aspects of illicit drug  
use in Australia
M o r b i d i t y  a n d  M o r ta l i t y
The use of illicit drugs by Indigenous people needs to be seen in 
the overall context of illicit drug use in Australia (for the extent 
of illicit drug use in Australia see appendix 1). Illicit drug use 
accounts for significant morbidity and mortality. There were 8,389 
hospital separations in Australia in 2005-06 for which the principal 
diagnosis was in relation to the four major illicit drug types 
(opioids, amphetamines, cannabis, and cocaine) [3]. For the period 
1993-2006, separations were highest for opioids across the entire 
period, followed by amphetamines, cannabis and cocaine [4].
In 2005, there were a total of 410 deaths in which opioids (n=374), 
methamphetamines (n=26) and cocaine (n=10) were determined 
to be the underlying cause of death among those aged 15-54 years 
[5, 6]. Opioid deaths are not necessarily due to heroin; for example, 
in Tasmania and the Northern Territory deaths are more likely to 
be related to pharmaceutical opioids [7]. Methamphetamine 
and cocaine were mentioned in a further 42 and 5 ‘drug-induced’ 
deaths respectively [6]. 
In 2003, illicit drug use accounted for 2% of the total burden of 
disease in Australia [8]. 
t h e  c o s t  o f  d r u g  u s e
The health and economic cost of drug use in Australia is significant. 
Collins and Lapsley (2008) estimated the total social cost (burden 
of disease) of drug use in Australia in 2004-05 to be $56.1 billion, 
of which $8.1 billion (15%) related to the cost of illicit drug use. In 
real terms, this represents an increase of 11.3% in the annual total 
social cost of illicit drug use in Australia from $6.1 billion in 1998-
99 (representing $7.3 billion in 2004-05 figures) to $8.1 billion in 
2004-05 [9].
In 2002-03, a total of $3.2 billion was spent by governments 
in relation to illicit drugs; law enforcement-related activity 
accounted for 75% of spending, and prevention, treatment, and 
harm reduction accounted for 10%, 7%, and 1% respectively [10]. 
Proactive spending (the direct actions of government in relation to 
drug policy), accounted for 42% ($1.3 billion) of total government 
expenditure; law enforcement-related activity accounted for more 
than half of proactive spending (56%), prevention, treatment, and 
harm reduction accounted for 23%, 17%, and 3% respectively [10].
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According to recent population surveys (2004-2005 National 
Aboriginal and Torres Strait Islander Health Survey (NATSIHS); 2007 
National Drug Strategy Household Survey (NDSHS)) the overall 
level of illicit drug use in the previous 12 months among the 
Indigenous population aged 15 years or older living in non-remote 
areas (28%) was more than twice the level of the general Australian 
population aged 14 years or older (13%) (Figure 1) [11, 12]. The 
higher level of drug use applied across all drug types.
For both the Indigenous population and the general Australian 
population cannabis was the most commonly used illicit drug. 
For the Indigenous population, cannabis was followed by 
amphetamines, analgesics (painkillers) and then ecstasy; in the 
general Australian population cannabis was followed by ecstasy, 
analgesics and then amphetamines [11, 12].
The overall level of illicit drug use in the previous 12 months by 
Indigenous people aged 15 years or older living in non-remote 
areas was 4.7% higher in 2004-2005 than in 2002 (Figure 2) [11]. 
This change reflects a 20% increase in the number of Indigenous 
people using illicit drugs in this 2-3 year period. The increase in 
cannabis use (18%) was around the same as the overall increase, 
but the increases in amphetamine and ecstasy use were much 
greater (46% and 137% respectively) [11]. For information on 
sources and limitations of information on illicit drug use among 
Indigenous people see appendix 2.
P o l y d r u g  u s e
Use of an illicit drug does not occur in isolation and is often 
associated with other health-risk factors. According to the 2004-
2005 NATSIHS, 12% of Indigenous males and 7% of Indigenous 
females had used three or more illicit substances in the previous 
12 months [11].
Generally, Indigenous people who had used illicit drugs in the 
previous 12 months were more likely than those who had never used 
illicit drugs to smoke (66% compared with 34%) and to consume 
alcohol at risky or high risk levels (28% compared with 13%) [15].
e v i d e n c e  f r o M  o t h e r  s o u r c e s
Age of first use
Data relating to the age of Indigenous people when they first use 
drugs is based mostly on small surveys (Cannabis: Gray et al, 1997; 
Dance et al, 2004; Clough et al, 2004. Injecting drug use: Larson, 1996; 
Shoobridge et al, 1998). It indicates that the mean age of first use 
for illicit drugs is up to 6 years younger than the national average: 
12-17 years for cannabis (18 years non-Indigenous) and 17-18 years 
for injecting drug use (21 years non-Indigenous) [12, 16].
The extent of illicit drug use among Indigenous people
evidence of illicit drug use aMong indigenous PeoPle – PoPulation surveys
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Cannabis use in remote communities
The use of cannabis by Indigenous people in remote communities 
in Arnhem Land has increased dramatically over the past 20 years or 
so [17]. Cannabis use was not detected in the ‘Top End’ communities 
in the mid 1980s, but the most recent research found 67% of males 
and 22% of females aged 13-36 years were currently using cannabis; 
these figures represent cannabis use among males more than twice 
that reported in the late 1990s for males aged over 15 years (31%) 
and cannabis use among females nearly three times that reported in 
the late 1990s for females aged over 15 years (8%).
In comparison with figures from the 2004-2005 NATSIHS, this equates 
to cannabis use among Indigenous males in remote communities 
more than twice that of their non-remote counterparts (28%), and 
cannabis use among Indigenous females in remote communities 
nearly one third higher than their non-remote counterparts (17%) [13].
Illicit drug use other than cannabis 
Emerging evidence supports a preference among Indigenous 
injecting drug users for amphetamines over heroin; this is most likely 
a reflection of the longer lasting euphoric effects of amphetamine 
and its economic affordability in comparison to heroin [18]. With 
evidence that amphetamine use is increasing among Indigenous 
people there are fears that non-Indigenous suppliers will use the 
existing, largely Indigenous, cannabis networks in rural and remote 
communities for the flow of amphetamines [19]. 
Figure 1. Proportions of illicit drug use in the previous 12 months for the 
Indigenous and general Australian populations, by drug type, 
Australia, selected years
Illicit drug use Cannabis Amphetamines Analgesics Ecstasy
Indigenous General Australian Population
Sources: 2004-2005 NATSIHS [13]; 2007 NDSHS [12]
note: Proportions are for: (1) indigenous people aged 15 years or older living 
in non-remote areas; and (2) general australian population aged 14 
years or older 
Figure 2.  Changes in proportions of Indigenous people using illicit drugs, 
by drug type, Australia, 2002 and 2004-2005
Illicit drug use Cannabis Amphetamines Analgesics Ecstasy
2002 NATSISS 2004-2005 NATSIHS
 
Sources: 2002 NATSISS [14]; 2004-2005 NATSIHS [13]
note: Proportions are for indigenous people aged 15 years or older living in 
non-remote areas
Polydrug use
c a n n a b i s  a n d  o t h e r  d r u g s
The studies of remote Indigenous populations in Arnhem Land 
found that tobacco smokers were more likely than non-smokers 
to use cannabis and that the likelihood increased as the quantity 
of cannabis used increased [20]. Cannabis users, who also smoked 
tobacco, reported smoking tobacco more heavily than non-users of 
cannabis (although tobacco use had been taken up more recently 
among cannabis users) [17]. For lifetime users of both tobacco and 
cannabis, one-third had initiated the use of both substances at the 
same time [20]. These findings suggest that for those who use both 
tobacco and cannabis it is likely that their use is heavy in relation to 
both drugs, with significant impacts on morbidity and mortality.
The Arnhem Land studies also found that petrol sniffers and those 
who used amphetamines were all cannabis users [17].
h e r o i n ,  a M P h e t a M i n e s  a n d  o t h e r  d r u g s 
A 2001 study of over 300 Indigenous people in South Australia 
who injected drugs (the largest single study of its type in Australia) 
found that most people were polydrug users, using about four 
different drugs within a six-month period. The most common 
variations were heroin, speed, cannabis, alcohol and tobacco. 
The drugs most often used in the previous 6 months were heroin 
(97%), speed (68%), alcohol (66%), cannabis (63%), tobacco (55%), 
benzodiazepines (34%) and methadone (34%) [21].
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Impact of Indigenous illicit drug use
h e a lt h  i M Pa c t s
Deaths and hospitalisation
National data on mortality among Indigenous people are not available 
[22], but data collated by the Health Department of Western Australia 
found that the deaths of 26 Indigenous males and 14 Indigenous 
females in 1990-99 had been attributed to the use of drugs other 
than alcohol or tobacco (age-standardised rates were 11.1 and 5.9 per 
100,000 population respectively) [23]. These death rates are similar 
to those for the total Australian population in 1999: 14 per 100,000 
population for males and 5 per 100,000 for females [24].
The only detailed information about hospitalisation as a result 
of illicit drug use was compiled as a part of reporting against the 
Aboriginal and Torres Strait Islander health performance framework 
[11]. Hospitalisation rates for drug-related causes were generally 
higher for Indigenous people than for non-Indigenous people 
living in Queensland, Western Australia, South Australia and the 
Northern Territory in July 2002 to June 2004 (comprising about 
60% of the total Indigenous population), particularly for mental/
behavioural disorders relating to use of cannabinoids and multiple 
drugs and psychoactive substances (Table 1).
The trend of increasing prevalence of illicit drug misuse among 
Indigenous people is reflected in studies by Patterson et al. (1999) 
and Gray et al. (2001) of increases in morbidity for drugs other than 
alcohol and tobacco in Western Australia between 1980 and 1995 
and 1994 and 2000. Significant increases in admissions for illicit 
drug use problems and increases in Hepatitis C notification rates 
and hospital admission rates for conditions related to illicit drug 
use were reported [23]. 
Hepatitis C and HIV/AIDS 
A large proportion of Indigenous users of amphetamines and 
opiates inject their drugs, with a high level of users sharing needles 
[2]. Findings from the South Australian study on Indigenous 
Table 1. Hospitalisation related to drug use, by Indigenous status and cause, Queensland, WA, SA and the NT, July 2002 to June 2004
Cause of hospitalisation Indigenous Non-Indigenous
Number Rate Rate Rate ratio
Poisoning
Psychotropic drugs, including antidepressants 258 0.4 0.4 1.1
Narcotics, including opium, heroin, methadone and 
cocaine
78 0.1 0.1 1.3
Accidental poisoning
Antidepressants and barbiturates 220 0.4 0.3 1.5
Narcotics (includes cannabis, cocaine, heroin, opium 
and methadone) and hallucinogens 
80 0.1 0.1 1.5
Mental/behavioural disorders
From use of cannabinoids 284 0.4 0.1 4.8
From use of multiple drugs and psychoactive 
substances
269 0.4 0.1 3.0
From use of other stimulants 226 0.4 0.2 2.0
From use of opioids 60 0.1 0.1 0.9
From use of sedatives 15 - 0.1 0.5
source: aihW, 2007 [11]
notes:  1 some of the causes of hospitalisation include non-illicit use of drugs
  2 rates are admissions per 1,000 population
  3 rate ratios are the indigenous rates divided by the non-indigenous rates prior to rounding of rates for presentation
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injecting drug users found that the people who regularly shared 
needles (12% of the surveyed participants) were more likely 
to be dependent, heavy polydrug users and frequent users of 
amphetamines [21]. These findings have implications for the 
spread of blood-borne viruses such as hepatitis C and HIV/AIDS. 
Although poor reporting systems make it difficult to determine 
the rate of viral infection among Indigenous drug users [2], the 
‘HIV/AIDS, viral hepatitis and sexually transmissible infections 
in Australia, Annual Surveillance Report 2007’ found that in the 
most recent five-year period (2002-2006), the rate of hepatitis C 
diagnosis increased in both the Indigenous and non-Indigenous 
population in the Northern Territory (in contrast with a decreasing 
trend nationally), but was lower in the Indigenous population. The 
rate of newly diagnosed hepatitis C infection in the Indigenous 
population of Western Australia and South Australia was between 
two and three times, and five and 10 times higher respectively 
than that in the non-Indigenous population [25]. This is likely to 
be a significant underestimation given that as recently as 2005 
Indigenous status was not recorded for 65% of new hepatitis C 
notifications [2]. 
Similarly, despite the similarity in HIV infection rates between 
Indigenous and non-Indigenous Australians, Indigenous 
Australians are more likely than non-Indigenous Australians to 
contract HIV infection through the use of shared needles. In the 
most recent five-year period (2002-2006), the ‘HIV/AIDS, viral 
hepatitis and sexually transmissible infections in Australia, Annual 
Surveillance Report 2007’ reveals a three-fold increase in the 
proportion of HIV infections attributed to injecting drug use among 
Indigenous Australians since the 2000 report (18% compared with 
6%), while the non-Indigenous rate has remained unchanged at 
3% [25, 26].
Overdose
The National Drug and Alcohol Research Centre (NDARC), in their 
report ‘Findings from the Illicit Drug Reporting System’ (IDRS), 
found that 56% of participants using heroin and other opioids in 
2007 had overdosed at some point in their lifetime. For participants 
who used amphetamines, 6% reported overdosing at some point 
in their lifetime [7]. In 2005, 46% of injecting drug users surveyed in 
Australia had overdosed at some point in their lifetime [8].
In 2001, a Western Australian study of 74 Indigenous people who 
inject drugs found that 24% of participants had overdosed at some 
time [27]. The authors note that these findings contrast with the 
findings of Larson (1996), where 52% of Indigenous heroin users 
had personally experienced overdose, however the lower overdose 
rate in the Western Australian study was attributed to a lesser use of 
heroin [27]. In 2001, a South Australian study of Indigenous injecting 
drug users found that 21% had overdosed after injecting, and, in 
contrast to the Western Australian study, 97% of participants had 
used heroin in the previous six months [21]. These figures suggest 
the overdose rate for Indigenous injecting drug users is variable; 
being less than or equal to that of the general Australian injecting 
drug user population. The concern for Indigenous injecting drug 
users relates to the stigma and shame of injecting drug use and 
the associated increased risks of overdose when injecting alone to 
conceal drug use from family and friends [28].
Social and emotional wellbeing
The 2002 NATSISS found that Indigenous people experience 
stressors in their lives at a rate one and a half times that of the 
non-Indigenous population [14]. The most common stressors 
reported in the 2004-05 NATSIHS were the death of a family 
member or close friend (42%), serious illness or disability (28%), 
alcohol and other drug related problems (20%), family member in 
jail (19%), and inability to get work (17%) [15]. Indigenous people 
are also hospitalised for mental disorders at twice the rate of other 
Australians, with the greatest excess of mental health-related 
hospitalisations in the younger adult age groups and the greatest 
excess of mortality in the 35-54 year age group [1].
Findings from hospital data and mental health service providers 
suggest Indigenous people have significantly more mental health 
disorders associated with illicit drug misuse than non-Indigenous 
Australians. The National Hospital Morbidity Database found that 
Indigenous Australians were hospitalised for mental/behavioural 
disorders from use of cannabinoids and from use of multiple 
drug and psychoactive substances at a rate 5 times and 3 times 
respectively that of non-Indigenous Australians [11]. Similarly, 
Indigenous people presenting to public mental health services 
were nearly 3 times more likely to have a principal diagnosis of 
disorders due to psychoactive substance use than non-Indigenous 
Australians (8% compared with 3%) [29].
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Co-morbidity 
Co-morbidity is the co-occurrence of more than one disease or 
disorder in an individual. It is known that mental health problems 
co-occur with drug use problems and that both may influence each 
other. Co-morbidity of substance use disorders with psychosis, 
anxiety, affective, personality and other substance use disorders is 
widespread and treatment outcomes are often poor [30]. 
The National Survey of the Mental Health and Wellbeing of 
Adults (SMHWB) conducted in Australia in 1997 provided 
information on the prevalence of mental disorders, including 
anxiety, affective and substance use disorders among the 
Australian population. Although a significant survey, and the 
first of its kind, it did not cover people in remote areas and the 
number of Aboriginal and Torres Strait Islander people who took 
part in the survey was too small to provide reliable estimates of 
their mental health [31, 32].
The SMHWB found significant rates of comorbidity among the 
general Australian population. Of those with a substance use 
disorder, 31% also had another mental disorder [32]. Although there 
are no comprehensive studies of co-morbidity among Indigenous 
people it is likely that the rates of co-morbidity are higher than 
those of the general population [2]. 
Suicide
Over the last decade the Indigenous suicide rate has grown 
compared with that of non-Indigenous people [15]. For the period 
2001-2005, the Indigenous suicide rate was 3 and 4 times higher 
for males (0-24 years and 25-34 years respectively) and 5 times 
higher for females (0-24 years) compared with the corresponding 
age-specific rates for non-Indigenous males and females. Between 
1997 and 2000 the Indigenous suicide rate was 1.8 times higher 
for males and 1.3 times higher for females than for their non-
Indigenous counterparts [16].
Whereas alcohol remains the drug most associated with suicidal 
ideation, various studies have shown that intoxication from drugs 
other than alcohol also facilitates the suicide decision: Clough 
and colleagues (2006) found a slight increase in the incidence of 
self-harm (including suicide attempts) among cannabis users; 
Shoobridge and colleagues (1998) found that more than half of 
injectors had attempted suicide at least twice, and just over 90% of 
those attempting suicide were intoxicated at the time [16]. In the 
Northern Territory there has been an 800% increase in Indigenous 
suicide over the period 1981 – 2002. Those most at risk are 
Indigenous males aged 45 years and under. In 2000-2002 misuse of 
drugs other than alcohol was identified in 16% of cases [33]. 
i M Pa c t  o n  fa M i l i e s 
Relationships 
The impact of drug use on families is significant. In an Adelaide 
study of Indigenous injecting drug users in 2001, half of those 
interviewed cited family breakdown as a result of injecting drug 
use [21]. Similarly, in a Western Australian study in 2001, users were 
overwhelmingly more concerned about the impact of their drug 
use on family and close relationships (60%) than the impact on 
their own health (9%) [27]. Relationships suffer on many levels, and 
a constant tension relates to sourcing money for substance use 
[19].
Violence
Family violence was a recurring concern of community members in 
remote areas; the heavy use of cannabis was believed to compound 
the violence arising from the use of alcohol, kava or inhalant misuse 
[19]. The majority of police in remote areas (76%) also believed 
cannabis use contributed to domestic/family violence. 
The increasing levels of amphetamine use (especially among those 
with a predisposition for violence) is also likely to increase the 
levels of violence in communities already experiencing high levels 
of violence [18]. 
Whereas illicit drug users are often associated with the perpetration 
of violence, Indigenous Australians who used at least one illicit 
drug in the previous 12 months were more than twice as likely to 
have been a victim of physical or threatened violence compared 
with those who did not use illicit drugs (41% compared with 18%) 
[29].
Child harm
In remote areas, communities expressed concern for child neglect 
and the sexual exploitation of young people in relation to drug use 
[19]. This concern was echoed by police who associated cannabis 
use with disruption to schooling and with children trading sexual 
favours for money or drugs. 
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The influence of parental illicit drug use on children was highlighted 
in a West Australian survey which found that children of parents 
who used drugs other than alcohol or tobacco were more than 
twice as likely to use marijuana than children whose parents did 
not use illicit drugs (24% compared with 11%), were more likely 
to both smoke and to use marijuana and were more likely to drink 
alcohol and to drink to excess than those children whose parents 
did not use illicit drugs [34].
c r i M e  a n d  i n c a r c e r at i o n
Indigenous people are incarcerated at highly disproportionate 
rates compared with the non-Indigenous population. Data from 
the National Prisoner Census showed that at 30 June 2007, 6,630 
prisoners were Indigenous – an increase of 9% on 2006 numbers 
and representing 24% of the total prisoner population (unchanged 
from 2006). Using age-standardised rates, Indigenous people 
were 13 times more likely to be in prison than non-Indigenous 
people (also unchanged from 30 June 2006); in Western Australia 
Indigenous people were 21 times more likely to be in prison than 
non-Indigenous people - the highest Indigenous to non-Indigenous 
rates of imprisonment in Australia [35].
In 2005, data from the Australian Institute of Criminology (AIC) 
Drug Use Monitoring in Australia (DUMA) survey (carried out 
in Queensland, New South Wales, South Australia and Western 
Australia), which collects information on illicit drug use from 
recently arrested detainees, found that positive drug tests were 
returned for a higher proportion of Indigenous detainees than non-
Indigenous detainees in all seven of the police stations surveyed; 
the proportion returning positive drug tests ranged from 62% and 
85% for Indigenous detainees compared with 47% and 73% for non-
Indigenous detainees. For both Indigenous and non-Indigenous 
detainees who tested positive to drugs, cannabis was the most 
common drug and benzodiazepines and methamphetamine were 
also common [11]. 
Examination of the 2002 NATSISS found that the two most 
important factors relating to Indigenous prosecution and 
imprisonment were high-risk alcohol consumption and illicit drug 
use [36]. Use of certain drugs is, to some degree, associated with 
specific criminal activities: cannabis and inhalant use is associated 
with property damage, intravenous drug use is associated with 
sex work, and alcohol is associated with violence. Various studies 
have shown that the more common forms of criminal activities 
carried out by Indigenous drug users are stealing, break and entry, 
vandalism, gambling, dealing and violent crime such as assault. [16]. 
Supporting this, data from the National Prisoner Census showed 
that at 30 June 2007, acts intended to cause injury and unlawful 
entry with intent accounted for over 43% (2,204) of imprisonment 
for Indigenous prisoners [35].
e c o n o M i c  c o s t s
In remote communities it is likely that substance users spend a 
significant proportion of their income on cannabis alone: up to a 
third of their weekly median income of $160/week for those aged 
13-36 and representing 6-10% of the total monetary resources in 
these communities [17]. While much of this money remains in the 
community, it places significant strain on the users themselves 
and their families. In a South Australian study in 2001, Indigenous 
injecting drug users experienced significant financial problems 
[21]. The average weekly expenditure on injectable drugs among 
Indigenous users ranged from $50 to $2100, with the median cost 
per ‘taste’ being $75. This spending occurred within the context of 
a median average income of $350 per week [16].
The high costs associated with funding illicit drug dependence account, 
at least in part, for the increased rate of involvement in crime [36].
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h i s t o r i c a l  c o n t e x t  o f 
i n d i g e n o u s  d i s a d va n ta g e  a n d 
i l l i c i t  d r u g  u s e
A political economy perspective of Indigenous disadvantage 
views political and economic factors as broadly determinative 
of the more microbiological, psychological and social/cultural 
factors that influence the behaviour of individuals and groups 
[37]. Indigenous people experience significant disadvantage 
across all socioeconomic indicators, including income, education, 
employment and housing conditions [29]. Gray and colleagues 
(2007) illustrate that the root of this disadvantage lies in the 
dispossession and oppression of Indigenous people since the 
arrival of the British in 1788 [2]. The British claimed Australia on 
the grounds of terra nullius (a legal term meaning the land was 
unoccupied and belonged to no one) despite the fact that an 
estimated 750,000 people lived in Australia, with ancestry dating 
back more than 60,000 years. Around the turn of the twentieth 
century ‘social Darwinism’ (which held that less technologically 
complex societies would give way to more technologically 
complex societies) was used to justify the continued dispossession 
of Indigenous people. It was considered that Indigenous people 
would die out, a belief that was actively assisted through the 
establishment of poorly resourced missions and government 
settlements which closely regulated every aspect of Indigenous 
lives. In this environment children of mixed descent were taken 
from their parents and their culture ‘for their own good’. Indigenous 
people were denied access to mainstream society; education was 
denied and employment was limited to the most basic and menial 
roles. Such overt discrimination continued through until the 
implementation of policies of assimilation from the 1950s, but it 
was not until 1962 that Indigenous people were able to vote and 
it was not until 1967 that the Commonwealth could pass laws in 
relation to Indigenous people. 
The period of assimilation denied Indigenous people their culture 
and gave way to policies of self-determination in the 1970s, but this 
era ended in non-Indigenous declarations of failure and a return 
to more assimilationist policies in the beginning of the twenty 
first century [2]. Within this political economy context the social 
determinants of health weigh heavily on Indigenous people. 
s o c i a l  d e t e r M i n a n t s  o f  h e a lt h
Education
Education is a critical pathway to employment opportunities 
and associated increased living standards. In 2007, the Australian 
Bureau of Statistics and Australian Institute of Health and Welfare 
(2008) reported that the retention rates for Indigenous people in 
years 10, 11 and 12 were around 10%, 20% and 30% less respectively 
than the non-Indigenous retention rates for those years. In 2006, 
Indigenous people aged 15 years and over were half as likely as 
non-Indigenous people to have completed school to year 12 (23% 
compared with 49%) and twice as likely to have left school at year 
9 or below (34% compared with 16%). Indigenous people living 
in rural areas and remote areas were less likely to have completed 
year 12 than their urban counterparts (22% and 14% respectively 
compared with 31%). [15]. Lowell and colleagues (2003), found 
that Indigenous people from rural and remote communities in 
the Northern Territory believe that the loss of cultural knowledge 
has contributed to the poor health status of their people and that 
better health is not dependent on improved Western education, 
but rather cultural education related to health issues, cultural 
systems and knowledge [cited in 38]. Schwab (2006) provides 
support for these beliefs, suggesting that the quality and cultural 
appropriateness of education are important factors in determining 
the influence of education on health outcomes for Indigenous 
people [cited in 38].
Various studies have explored the link between educational 
outcomes and substance use: a study of two remote communities 
in Arnhem Land found that current cannabis users were less likely 
to participate in education or training [17]; in an Adelaide study 
of  injecting drug users the average age of leaving school was 15 
years [21]; and a study by Gray and colleagues (1997), showed that 
children aged 8-17 disaffected from school were 23 times more 
likely to be ‘polydrug users’[23]. 
Employment
As with education, the relationship between employment and 
drug use is circular. An environment of underemployment or 
unemployment is more likely to sustain drug use, and established 
drug use is more likely to inhibit the ability or desire to work [16]. 
In 2006, one-third (33%) of Indigenous young people (aged 18-24 
years) were fully engaged in work or study; less than half the rate 
of non-Indigenous young people (71%). In remote areas, less than 
one-fifth (18%) of Indigenous young people (aged 18-24 years) 
were fully engaged in work or study [15]. 
The low rates of engagement in work or study for Indigenous 
people compared with non-Indigenous people can be related 
to the higher rate of drug use in the previous 12 months for 
Indigenous people aged 15 years or over compared with non-
Indigenous people aged 14 years and over (28% compared with 
13%) [11, 12]. For Indigenous people in remote areas the lower rate 
of engagement in work or study compared with Indigenous people 
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in non-remote areas reflects an even greater rate of illicit drug use: 
in remote communities, 67% of males and 22% of females aged 
13 years and over currently used cannabis compared with 28% of 
males and 18% of females aged 15 years and over in non-remote 
areas [11, 17]. These figures represent an inverse relationship 
between active engagement in work or study and drug use. 
Similarly, low employment rates were characteristic of injectors 
in an Adelaide study in 2001 where two-thirds were unemployed 
and only 3% had stable employment. [21]. Polydrug use may also 
be more common among the unemployed: most injectors in the 
Adelaide study cited above were polydrug users and unemployed 
youth aged 15-17 were 13.5 times more likely to be ‘frequent 
polydrug users’ [23].
Income 
Studies show a clear and consistent relationship between individual 
level of income and level of morbidity and mortality, with the 
highest rates of morbidity and mortality experienced by those 
on the lowest income [22]. In 2006, the median equivalised gross 
household income of Indigenous Australians was equal to 56% that 
of non-Indigenous Australians ($362 compared with $642) [15].
The relationship between income and health status has been 
contested at the population level for Western industrialised 
countries where an association between income and life 
expectancy has not been found. Attention has therefore focused 
on the contextual effects of inequality; the way in which factors 
such as social status rather than income per se influence health 
status. For Indigenous Australians the experience of ‘long-term 
social exclusion and material marginalisation’ is manifest in their 
much lower life expectancy [22]. How low income and low social 
status impact on illicit drug use relates to the association between 
social determinants such as unemployment, homelessness and 
poverty and behaviours that damage health - including illicit 
drug use; some have found the association is strongest between 
deprivation and licit and illicit drug use, but evidence suggests 
that this association is mediated by risk and protective factors 
[22]. Importantly, Indigenous poverty cannot be viewed directly 
through the lens of mainstream social determinant models of 
health without also considering the complex interplay between 
the ‘social, political and economic consequences of being an 
Indigenous person in Australia’ [39]. 
Housing
Overcrowding is associated with adverse health outcomes, 
including higher rates of smoking and drinking at hazardous levels 
[15]. In 2006, around one-quarter of the Indigenous population 
(27% or 102,300 people) were living in overcrowded conditions; 
23% of Indigenous households had 5 or more people resident, and 
in Indigenous or mainstream community housing (representing 
55% of the housing tenure in remote areas) an average of 4.8 
people are resident per household [15].
No specific studies have investigated the relationship between 
overcrowding and illicit drug use, but it seems likely that rates of 
illicit drug use would also be higher. The Northern Territory’s Select 
Committee on Substance Abuse in Communities (2007) found that 
levels of stress attributable to overcrowding resulted in greater 
harms from substance abuse and recommended that the highest 
priority be given to alternatives to current approaches to housing 
in remote communities [40].
fa M i ly  a n d  s o c i a l  fa c t o r s
Family functioning and resilience are protective factors just as 
family stressors (grief, domestic violence, ‘absent’ parents) are risk 
factors. Family stressors are commonplace in communities where 
substance use is problematic [16].
Inducement by friends, or peer pressure, is a major influence in the 
initiation of drug taking. Among the general Australian population 
peer pressure was the second most common factor for first use (54%) 
after curiosity (77%) [41]. The influence of the peer group is likely to 
be stronger among those for whom home life is stressful [16]. 
In communities where drug use is not problematic it has been 
found that meaningful activity (and not necessarily paid work) is a 
protective factor. So too, recreational activities including sport and 
cultural activities are considered a crucial primary intervention, 
particularly in those areas where there is little structured social 
activity [16].
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n at i o n a l  s t r at e g i c  f r a M e W o r k 
f o r  a b o r i g i n a l  a n d  t o r r e s 
s t r a i t  i s l a n d e r  h e a lt h  2 0 0 3 - 2 0 1 3 
( n s fat s i h )
The NSFATSIH is historically based in the articulation of the health 
aspirations of Indigenous Australians as set out in the National 
Aboriginal Health Strategy (1989) [42]. The NSFATSIH aims to 
direct government action using a coordinated, collaborative and 
multi-sectoral approach [43].  Social and emotional wellbeing is 
a priority area of the framework which recognises the impact of 
alcohol and other drug misuse on the health and wellbeing of 
Indigenous people. The NSFATSIH supports the aims and activities 
of the National Drug Strategy Aboriginal and Torres Strait Islander 
Peoples’ Complementary Action Plan [43].
t h e  n at i o n a l  d r u g  s t r at e g y
The National Drug Strategy (developed by the Ministerial Council 
on Drug Strategy (MCDS)) is an umbrella framework which seeks to 
reduce the harmful effects of drugs and drug use through a series 
of national action plans addressing tobacco, alcohol, school-based 
drug education and illicit drugs [44]. 
Harm minimisation
Since 1985 Australia’s drug strategy has embraced the principle of 
harm minimisation to reduce drug-related harm. Harm minimisation 
refers to the policies and strategies of supply reduction, demand 
reduction and harm reduction which seek to reduce drug-related 
harm by improving the health, social, and economic outcomes for 
both the individual and the community  [44]. 
Supply reduction strategies seek to reduce the production and 
supply of illicit drugs and to control and regulate licit drugs [45].
Demand reduction strategies seek to reduce demand for substances 
and include strategies aimed at preventing the uptake of harmful 
drug use as well as strategies aimed at reducing drug use [45]
Harm reduction strategies seek to reduce drug-related harm for individuals 
and communities while not necessarily reducing drug use [45]
Funding
In 2002-03, proactive spending (the direct actions of government 
in relation to drug policy), accounted for 42% ($1.3 billion) of total 
government expenditure in relation to illicit drugs ($3.2 billion); 
law enforcement-related activity accounted for more than half 
of proactive spending (56%), prevention, treatment and harm 
reduction accounted for 23%, 17%, and 3% respectively [10]. 
n at i o n a l  d r u g  s t r at e g y 
a b o r i g i n a l  a n d  t o r r e s 
s t r a i t  i s l a n d e r  P e o P l e s ’ 
c o M P l e M e n ta r y  a c t i o n  P l a n 
2 0 0 3 - 2 0 0 9 
The Aboriginal and Torres Strait Islander Complementary Action 
Plan was developed in recognition of the particular challenges 
Indigenous people are faced with in reducing the harm arising from 
substance use and provides national direction for the reduction 
of harm, complementing all other existing national action plans 
under the National Drug Strategy Framework [44]. 
Roles and responsibilities
The Aboriginal and Torres Strait Islander Peoples’ complementary 
action plan stresses the need for a whole-of-system response 
based on effective partnerships across levels of government, across 
portfolios, with Aboriginal and Torres Strait Islander community-
controlled organisations, and with the communities themselves to 
ensure the best use of available resources in minimising the harms 
arising from substance use [46]. 
Key result areas
The following six key result areas shape the action plan [16]:
•	 building individual, family and community capacity to address 
current and future issues in the use of alcohol, tobacco and 
other drugs, and promote their own health and wellbeing
•	 actively promoting a whole-of-government commitment, 
alongside collaboration with community-controlled services and 
non-governmental organisations, in reducing drug-related harm
Policies and strategies addressing illicit drug use among Indigenous people
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•	 improving access to the appropriate range of health and 
wellbeing services that play a role in addressing alcohol, 
tobacco and other drug issues
•	 recognising the role of holistic approaches from prevention 
through to treatment and continuing care that is locally 
available and accessible
•	 introducing and improving workforce initiatives to enhanced 
capacity of community-controlled and mainstream 
organisations to provide quality data
•	 increasing ownership and sustainable partnerships for research, 
monitoring, evaluation and dissemination of information
Performance indicators
The National Illicit Drug Action Plan performance indicators are as 
follows [46]:
•	 prevalence of use in the previous 12 months in the general 
population and by young people under 25 years of age
•	 perception that it is all right to use drugs regularly (at least 
monthly)
•	 purity and price of illicit drugs
•	 number of community-based episodes of care
•	 number of people diverted to treatment from the police
•	 participation in treatment by Aboriginal and Torres Strait 
Islander peoples’, and people from culturally and linguistically 
diverse backgrounds
•	 number of people receiving methadone treatment at mid-year 
census
•	 number of fatal overdoses
•	 incidence of HIV diagnoses attributable to injecting drug use
•	 illicit drug use among arrestees
Specific national indicators for the National Aboriginal and Torres 
Strait Islander Complementary Action Plan 2003-2006 are [46]:
•	 an increase in the capacity to report nationally on improvements 
for Aboriginal and Torres Strait Islander populations in meeting 
the mainstream performance indicators specified by the 
substance-specific national action plans
•	 the number of regional health plans developed under the 
partnership agreements that incorporate ATOD strategies 
listed in the complementary action plan
•	 evidence that all appropriate workforce, research, and 
evaluation and monitoring actions that arise from funding for 
the substance-specific action plans are developed in line with 
the intentions of the complementary action plan to improve 
capacity and to promote holistic models of intervention
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Services
Services provided to Indigenous people for substance misuse can be 
conceptualised using the harm minimisation framework of Australia’s 
National Drug Strategy. This framework uses demand reduction, 
harm reduction and supply control strategies (explained above) in a 
tripartite approach to interventions to reduce substance misuse [47].
The interventions under this tripartite approach can be categorised 
as primary, secondary or tertiary [47]. Primary interventions are 
those which seek to prevent the uptake of substance use in the 
first place; secondary interventions are those which address the 
needs of the user and the problems associated with that use for 
the individual and the community; tertiary interventions are those 
which address the treatment and rehabilitation of chronic users as 
well as the interventions required for those impaired as a result of 
their use [16].
d e M a n d  r e d u c t i o n
Primary interventions
Primary intervention includes strategies addressing the broader 
social determinants of health as well as health sector specific 
strategies focussing on education and information on the risks 
associated with drug use [47].
s o c i a l  d e t e r M i n a n t s  o f  h e a l t h
It is widely acknowledged that interventions need to address the 
social determinants of health that propel Indigenous Australians 
into drug use [16]. The most essential determinant being education, 
and particularly secondary education and youth training whereby 
meaningful employment and recreation are requisite for stemming 
the tide of boredom, frustration and directionless experienced by 
so many young Indigenous people.
r e c r e a t i o n
The introduction of recreational activities is especially important in 
regional and remote settings where few opportunities for recreational 
activity exist. d’Abbs and McLean (2000) found that success is more 
likely if a wide range of activities are provided encompassing a greater 
range of interests inclusive of gender relevant interests [16]. Likewise, 
the Northern Territory’s Select Committee on Substance Abuse in the 
Community (2007) found that the provision of recreational activities is 
a major element of demand reduction and the key to guiding young 
people away from substance misuse and therefore recommended 
recreation facilities be accorded due significance in funding priorities 
by government [40].
e d u c a t i o n / i n f o r M a t i o n  o n  d r u g  u s e
Gray and colleagues (2004) describe a range of culturally specific drug 
use education interventions; health promotion projects including 
theatre which reflects local and regional circumstances, advertising 
through regional Indigenous television, and promotional materials 
developed by Aboriginal community controlled health services 
(ACCHSs) using local people on posters and pamphlets. State 
and territory health departments have also produced culturally 
appropriate and relevant health promotion materials [47].
The Australian Government funded Aboriginal and Torres Strait 
Islander Primary Health Care Services, Service Activity Reporting 2003-
04 Key Results (SAR) found that all services provided ‘health promotion/
education’ but as this is not broken down into specific areas it is not 
possible to determine what percentage of interventions applied 
to substance use health promotion [48]. Less than 5% of Australian 
Government funded Aboriginal and Torres Strait Islander Substance 
Use Specific Services provided community-based education and 
prevention programs [49]. Australian Government funded alcohol and 
other drug treatment services in Australia provided information and 
education to 11% of Indigenous clients [50].
s c r e e n i n g
In 2004-2005, 20% of Indigenous people had seen a general 
practitioner in the previous two weeks and 17% had seen an 
Aboriginal Health Worker in the previous two weeks [13]. Primary 
health care settings, therefore, provide an ideal opportunity 
to identify substance use through programs such as ‘Ferret’; a 
program widely used in ACCHSs which prompts staff to ask about 
alcohol and tobacco consumption as part of annual health checks 
[47].
Secondary and tertiary interventions
Secondary interventions include ‘brief intervention’; the advice 
given by health practitioners on reducing or giving up substance 
use. Tertiary interventions include treatment, rehabilitation and 
counselling of chronic drug users [47].
b r i e f  i n t e r v e n t i o n s
Brief intervention describes strategies including screening, 
brief advice, referral to specialist support, counselling and brief 
motivational interviewing [51]. In a study to determine the 
feasibility and acceptability of providing brief intervention in an 
urban Indigenous health setting, brief intervention was found 
to be ‘culturally appropriate, but barriers to wider administration 
included lack of time and the complexity of patients’ presenting 
health problems’ [51, p. 375]. It was also found that the research 
raised awareness of the utility of brief intervention for substance 
use in primary health care settings.
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The use of primary health care services by Indigenous people (as 
cited above) provides the ideal opportunity for ‘brief intervention’ 
for those for whom substance use has become problematic [47]. 
t h e  i l l i c i t  d r u g  d i v e r s i o n  i n i t i a t i v e 
( i d d i )  i n  r u r a l  a n d  r e M o t e  a u s t r a l i a 
The IDDI is an initiative of the Council of Australian Governments 
(COAG) which sought early intervention in the prevention of a new 
generation of drug users. The strategy involves diverting offenders 
who have had little prior contact with the justice system for drug 
offences, and/or whose apprehension involves a small quantity of 
illicit drugs, into appropriate drug treatment services. Diversion 
can occur via the police or the courts [52].
As at June 2006, 22 of the 32 IDDI-funded programs were 
operating in rural and remote areas. The IDDI has been responsible 
for increasing the pathways to drug assessment, education and 
treatment through the police and court diversion programs as 
well as increasing the number of locations where alcohol and 
drug workers operate. The IDDI has also served to increase the 
involvement of service providers in the assessment, education and 
treatment of people diverted under the program in 231 rural and 
remote locations [52].
The IDDI has limited quantitative data about the outcomes 
of those who have attended diversion programs. In 2005-06, 
compliance rates indicated that completion for police diversion 
programs ranged from 56% to 95%, while completion for court 
diversion programs ranged from 29% to 100%. The extent of 
positive outcomes for clients (aside from completion rates) cannot 
be determined due to insufficient evidence, although many service 
providers believe diversion provides a valuable opportunity to 
access this important client group [52].
t h e  a l c o h o l  a n d  o t h e r  d r u g  t r e at M e n t 
s e r v i c e s  i n  au s t r a l i a  2 0 0 6 - 0 7  –  r e P o r t  o n  t h e 
n at i o n a l  M i n i M u M  d ata  s e t  ( a o d t s - n M d s )
The AODTS-NMDS includes Australian Government funded agencies 
(government and non-government) providing alcohol and/or 
other drug treatment services. Services which do not fall within 
the scope of the AODTS-NMDS include Aboriginal and Torres Strait 
Islander substance use specific services and health care services, 
treatment services based in prisons, agencies providing overnight 
stays such as ‘sobering-up shelters’ and health promotion services 
such as needle and syringe exchange programs [50]. 
A closed treatment episode is defined as a period of contact 
having defined dates of commencement and cessation between 
an agency and a client. In 2006-07, Indigenous clients comprised 
one in ten closed treatment episodes (10%), unchanged from the 
previous three reporting periods [50].
Treatment episodes among the 10-19 years age group were 
more common for Indigenous clients than for non-Indigenous 
clients (18% compared with 11%); for those aged over 40, 
Indigenous clients were less common than non-Indigenous 
clients. These differences may relate to the younger age structure 
of the Indigenous population compared with the non-Indigenous 
population [50].
Indigenous clients reported the same drugs of concern as the total 
population - alcohol, cannabis, opioids and amphetamines; alcohol 
was more likely to be nominated by Indigenous clients (49% 
compared with 42%) and opioids were less likely to be nominated 
by Indigenous clients (11% compared with 15%). 
The main treatment types involving Indigenous clients were 
counselling (38%), assessment (18%), withdrawal management 
(detoxification) (12%), and information and education (11%). 
Indigenous clients were less likely to receive withdrawal 
management than non-Indigenous clients (12% compared with 
17%), and more likely to receive information and education only, 
and assessment only, than non-Indigenous clients (11% and 18% 
compared with 9% and 14%) [50].
a b o r i g i n a l  a n d  t o r r e s  s t r a i t  i s l a n d e r 
s u b s t a n c e  u s e  s P e c i f i c  s e r v i c e s
In 2005-06, 37 out of 40 Australian Government funded Aboriginal 
and Torres Strait Islander substance use specific services (which 
comprised 27 residential and 13 non-residential services) 
responded to the Drug and Alcohol Services Report (DASR) [49].
An episode of care is defined as contact between a client and a 
staff member and, in contrast to the AODTS-NMDS, any change in 
treatment or drug of concern does not constitute a new episode of 
care [50]. Residential episodes of care begin at admission and end 
at discharge [49]. In the case of ‘other care’ (non-residential care), 
higher estimates of activity will be recorded as this relates to the 
number of visits or phone calls between the service and clients. 
Clients are counted only once regardless of how many times they 
access assistance during the reporting year [49].
In 2005-06, 28,200 clients were seen by DASR services, of which 
21,400 were Indigenous (76%). Approximately 1,900 Indigenous 
clients received residential care involving 3,700 episodes of care. 
Approximately 13,000 Indigenous clients received non-residential 
care involving 49,200 episodes of care [49].
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The principal drugs of concern treated by DASR were alcohol, 
cannabis, amphetamines, tobacco and benzodiazepines [49]. This 
differs from the AODTS-NMDS which includes opioids in the top 
four drugs of concern.
The most common methods of providing care reported by DASR 
services included transport (100%), counselling (97%) and referral 
services (97%). The most frequently used substance use treatment 
approach by DASR services was abstinence (43%) [49]. These 
findings cannot be compared with the AODTS-NMDS because they 
relate to the services provided and approaches used by the services 
rather than the numbers of clients receiving those services.
a b o r i g i n a l  a n d  t o r r e s  s t r a i t  i s l a n d e r 
P r i M a r y  h e a l t h  c a r e  s e r v i c e s
In 2003-04, 139 of 140 Australian Government funded Aboriginal and 
Torres Strait Islander primary health care services responded to the 
Service Activity Reporting (SAR), of which, 138 provided usable data [48]. 
An episode of care is defined as contact between a client and health 
service staff for the provision of health care. Approximately 88% of 
health care episodes were provided to Aboriginal and Torres Strait 
Islander clients.
At least one substance use program targeting cannabis was offered 
by around 50% of services and up to 25% of services offered 
programs for illicit drugs other than cannabis; principally opiates, 
benzodiazepines and amphetamines. Programs addressing 
multiple drug use were offered by 30% of services. More generally, 
substance use issues are covered on an individual client basis as 
they arise in the course of client care [48].
h a r M  r e d u c t i o n
Secondary intervention 
Loxley and colleagues (2004) noted the programs with the strongest 
evidential support for harm reduction were: needle and syringe 
distribution to reduce the spread of blood-borne viruses; the use of 
methadone for opiate dependence to reduce the risk of overdose 
and blood-borne viruses; and hepatitis B vaccinations [22].
In 2005-06, the DASR found that 27% of services used harm 
reduction interventions (such as information about safe using 
practices) in relation to substance use, and approximately 1,170 
Indigenous clients received sobering up/residential respite 
involving 5,220 episodes of care [49]. In terms of injecting drug 
users, in 2003-04, 30 ACCHSs (22%) operated needle exchange 
programs [2].
b a r r i e r s  t o  t r e at M e n t 
Barriers to treatment for Indigenous people relate to the availability 
of services, the accessibility of services, the cultural appropriateness 
of services, the range of treatment options and the cost of services.
Availability of services
r e M o t e n e s s
The Australian Institute of Health and Welfare (2006) has 
acknowledged the barrier of geography in providing intervention 
services in remote communities [16]. Multi-function police facilities 
in remote areas of Western Australia (in which police share remote 
facilities with staff from the health, education and welfare sectors 
in an attempt to adequately respond to family violence and child 
abuse) may provide an opportunity to incorporate substance 
misuse services (to date, nine remote areas have been prioritised 
for multi-function police facilities) [53]. 
i d e n t i f i c a t i o n  o f  s e r v i c e  n e e d s
The Northern Territory’s Select Committee on Substance Abuse in the 
Community (2007) found that there was a lack of consultation with 
communities to ascertain their needs and resources and recommended 
a ‘community audit’ to ensure program provision is prioritised for 
individual communities [40]. Similarly, Teasdale and colleagues (2008) 
in their study assessing acceptability and accessibility of mainstream 
services for Indigenous Australians in a Sydney Area Health Service 
found that there was a lack of identification of the drug and alcohol 
needs of people living in the service area [54].
Accessibility of services
In 2005-06, all of the Australian Government funded Aboriginal 
and Torres Strait Islander substance use specific services who 
responded to the DASR (37 out of 40 services) provided transport 
services to clients [49]. This finding highlights the role the provision 
of transport services play in the accessibility of services. Similarly, 
where clients are not provided with transport to services there is a 
need for outreach services; Teasdale and colleagues (2008) identified 
a lack of outreach services for Indigenous clients needing to access 
mainstream services in a Sydney Area Health Service. Additionally, 
a narrow timeframe to access opioid pharmacotherapy was also 
identified as a barrier to accessibility [54].
Culturally appropriate services
The Australian Institute of Health and Welfare (2006) has highlighted 
the continuing need to ensure the cultural appropriateness of 
services. Services need to be more Indigenous ‘specific’, ‘friendly 
and accessible’, and ‘controlled’. In meeting these requirements 
non-Indigenous staff require cultural awareness training and 
adequate support (especially in remote areas) [16]. Similarly, 
Teasdale and colleagues (2008) identified the need for culturally 
appropriate clinical services including a culturally appropriate clinic 
environment, more Indigenous staff, cultural awareness training 
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for non-Indigenous staff, and holistic care including partnerships 
with Indigenous communities and community services [54].
Range of treatment options
The Australian Institute of Health and Welfare (2006) highlighted 
the need for the provision of adequate training in alcohol and other 
drug work for those staff whose skills are lacking, and importantly, 
to ensure treatment encompasses a broad range of options to 
minimise treatment drop-out rates reflective of restrictive and 
incompatible program availability. [16]. Limited treatment options 
identified by Teasdale and colleagues (2008) included a lack of 
brief intervention for Indigenous youth as well as limited access to 
hepatitis C assessment and treatment [54]. 
Cost of services
The Road to Recovery: Report on the inquiry into substance abuse in 
Australian communities (2003) found that naltrexone treatment for 
opioid dependent people, in contrast to alcohol dependent people, 
is not available through the Pharmaceutical Benefits Scheme and, 
at that time, incurred a cost of $167.00 for thirty 50mg tablets. 
The Road to Recovery report also found that the shift from public 
to private providers in the provision of methadone maintenance 
resulted in dispensing fees charged by pharmacists ranging from 
$3.50 to $7.00 per day, placing a considerable financial burden 
on those individuals already experiencing significant social and 
economic disadvantage [55]. Reflecting this burden of cost, 
Teasdale and colleagues (2008) identified a lack of subsidised 
pharmacotherapy dispensing in community pharmacies for 
Indigenous clients [54].
s u P P ly  r e d u c t i o n
Primary and secondary intervention 
Legislative and regulatory interventions in relation to the 
production, supply, possession and use of illicit substances are 
supply reduction strategies and can be categorised as both a 
primary and secondary prevention strategy; seeking to prevent the 
uptake of use by reducing demand, and minimising existing use by 
reducing supply [16].
Research by Loxley and colleagues (2004) showed limited evidence 
for supply reduction strategies and highlighted the need for 
much more research into those strategies in use [22]. National 
data from the Australian Crime Commission (2005) show that for 
2003-04 the number of arrests made in relation to drug offences 
is overwhelmingly for ‘consumption’ rather than supply (80% 
compared with 20%) [53]. It is unlikely that these arrests deter 
use given that there are high rates of re-offending among those 
convicted for illicit drug use [22]. 
Despite the limited evidence for supply reduction strategies, in 
2002-03, 75% of government spending in relation to illicit drugs 
was spent on crime-related consequences (reactive activity) 
and law enforcement-related activities (proactive activity) [10]. 
Similarly, Collins and Lapsley (1996) estimated that in 1992, over 
80% of Commonwealth and State government expenditure in 
relation to illicit drugs was allocated to law enforcement [56]. 
Those law enforcement strategies aimed at reducing demand among 
users which showed evidence for implementation included [22]: 
•	 combined law enforcement and community development; 
operating within a target area and combining partnership 
development, law enforcement targeting drug offenders, 
community policing, and community program and 
infrastructure development 
•	 use of civil penalties to control drug and disorder problems; 
typically aimed at non-offending third parties to take preventive 
action to end criminal or nuisance behaviour, for example, 
bans, injunctions, and restraining orders, and the fulfilment of 
health and safety regulations
•	 police crackdowns; designed to move drug dealers and sellers 
away from a particular area 
Law enforcement strategies aimed at suppliers of illicit drugs which 
showed evidence for implementation was limited to [22]:
•	 cannabis law reform; those policies designed to reduce 
penalties for cannabis possession or use
Weatherburn (2006) makes the point that supply reduction 
strategies are effective in reducing the harms of use by reducing the 
level of availability, and in fact, have been requested by Indigenous 
communities (as seen in dry-community initiatives). He espouses 
the argument for the effectiveness and necessity of supply 
reduction initiatives as highlighted by the work of Pearson, who 
views alcohol and other drug addiction as so endemic that they are 
now the principal cause of disadvantage rather than a symptom of 
it [57]. Pearson believes the ‘gammon economy’ (dependence on 
welfare and effective exclusion from the mainstream economy), 
and the ensuing lack of meaning and purpose, together with 
citizen rights that were equated with ‘drinking rights’, compounded 
the effects of dispossession and trauma for Indigenous people, 
leading to the epidemic of substance misuse and addiction 
based disadvantage [58]. These views support the initiatives 
of community driven supply control strategies to disrupt the 
‘normalisation’ of harmful substance use. 
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Policy implications
f u n d i n g
Loxley (2004) found that expenditure in Indigenous affairs over 
the past three decades has failed to meet the needs of Indigenous 
Australians or to remedy the social and economic inequalities that 
underlie and perpetuate substance misuse among Indigenous 
Australians. This inadequacy of funding includes health services 
and substance misuse services and has limited the ability to build 
capacity in communities and community organisations in regard 
to infrastructure, research capabilities and staff development and 
support [22].
The inadequacy of funding in substance misuse prevention and 
treatment services is, in part, a reflection of the national imbalance 
in expenditure in favour of law-enforcement. As cited previously, 
in 2002-03, government expenditure in relation to prevention, 
treatment and harm reduction accounted for only 10%, 7%, and 
1% respectively of total spending in relation to illicit drugs, and in 
terms of proactive spending (the direct actions of government in 
relation to drug policy),  prevention, treatment and harm reduction 
accounted for only 23%, 17%, and 3% respectively [10]. 
The disproportionate expenditure in relation to law-enforcement 
remains despite the Ministerial Council on Drug Strategy (2001) 
endorsing the statement that ‘treatment is one of the most 
effective strategies for preventing drug use, crime and the next 
generation of problems’ [59]. The cost effectiveness of addressing 
drug problems through treatment is supported by research 
from the United States which found that for every $1 invested 
in addiction treatment programs, a return in excess of $12 in the 
reduction of crime, criminal justice costs and health care savings 
could be made [60].
The views of Weatherburn and Pearson as to the efficacy of supply 
reduction (cited above) do not undermine the need for funding 
in prevention and treatment at least commensurate with that of 
law enforcement, but rather underline it (especially in relation to 
engagement with the ‘real economy’). Strategies to address drug-
related harms must necessarily address both the causes and the 
symptoms or risk the complexity of the symptoms (drug use and 
drug-related harms) overshadowing the causes. 
Funding which is insufficient and unbalanced undermines all of the 
key result areas of the National Drug Strategy Aboriginal and Torres 
Strait Islander Peoples’ Complementary Action Plan 2003-2009.
d ata
The Australian Institute of Health and Welfare (2006) recognises 
the need to improve the gaps in the information needed to 
discern the nature of substance use problems, the contextual 
factors underlying the prevalence and patterns of substance use, 
and the effectiveness of interventions. Planning, implementation, 
monitoring and evaluation of interventions cannot be considered 
truly reflective of, and responsive to, substance use and the 
harms associated with that use until data collection improves 
[16]. The most fundamental data gaps that need to be addressed 
are those which enable substance use and Indigenous status to 
be consistently recorded and therefore allow basic prevalence 
estimates across locations and population groups – such limitations 
reduce the usefulness of available information on, for example, 
contextual factors, information relating to patterns of substance 
use, and access to services [16].
h o l i s M
Loxley and colleagues (2004) have shown that the recognised link 
between underlying social factors and substance use has failed 
to result in a coordinated and holistic approach incorporating 
substance misuse policy and policies in other portfolio areas such 
as education, housing and employment. Further, Indigenous 
community-controlled organisations, all levels of government, and 
all sectors need to be involved in substance misuse interventions. 
The utility of Indigenous involvement in substance misuse 
interventions is highlighted in community action frameworks 
which emphasise local coalition empowerment and evidence-
based investment cognisant of local evidence of elevated risk 
factors and depressed protective factors [22]. 
P r i M a r y  h e a lt h  c a r e  s e rv i c e s
Demand and harm reduction strategies employed across the health 
sector to address substance misuse and substance misuse-related 
problems require a range of generalist and specialist agencies. 
Gray and colleagues (2004) highlight the potential role of primary 
health care providers in the provision of comprehensive substance 
misuse interventions - primary, secondary and tertiary, and as the 
centre of a network of agencies; able to take referrals from, and to 
provide referrals to, other treatment or support services. The key 
to successful primary health care provision of substance misuse 
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intervention is the availability of staff that have clearly defined 
substance misuse intervention roles (with adequate staff numbers 
for rotation and relief to prevent ‘burnout’), adequate training, and 
programs that reflect both the social determinants of substance 
misuse and the particular needs of the communities in which they 
will be implemented [47].
W o r k f o r c e  d e v e l o P M e n t
In 2002, funding provided for workforce development in substance 
misuse specific intervention projects was less than 3% [2].
Single and Rohl (1997), in their evaluation of the National Drug 
Strategy 1993-1997, recognised that a significant investment in 
workforce development was essential in improving outcomes in 
response to drug problems and recommended that training of 
mainstream health, law enforcement and community officials was 
required to effectively minimise drug-related harm, and that new 
developments in prevention, treatment and research needed to be 
more readily available to health care practitioners, law enforcement 
officers and the public at large [61].
Research findings highlight the necessity of comprehensive training 
for those people working in the field of substance misuse treatment. 
Intervention strategies for those with a substance misuse problem 
need to be cognisant of the stage of change that an individual is 
at in order to achieve successful behaviour change [62]. The most 
frequently used substance use treatment approach reported by 
DASR was abstinence, which highlights a likely mismatch between 
program provision and the client’s stage of change. Similarly, the 
IDDI (cited above) offers assessment, education and treatment 
to offenders diverted through police and court programs. The 
outcome of these programs (apart from completion rates) has not 
been evaluated but it is likely that interventions that do not match 
an individual’s stage of change are unlikely to be successful. 
d e M a n d  r e d u c t i o n
Social determinants of health
Research shows that those who have ‘a stake in life’ are more likely 
to succeed in addressing their substance misuse and highlights 
the fundamental significance of the social determinants of health 
[63]. A ‘stake in conventional life’ underpins successful ‘untreated’ 
behaviour change (natural recovery); those with the most resources 
and the most to lose from substance misuse are those most likely 
to terminate their problematic drug use without treatment. 
Conversely, those who experience a sense of hopelessness are 
least able to alter their drug taking behaviour. Social policy which 
attempts to increase a person’s stake in conventional life can serve 
to prevent future substance misuse as well as provide an anchor for 
those who become dependent.
The need for a structured approach
A widespread and structured approach to primary prevention 
at the individual and community level is likely to have the most 
significant effect on preventing substance use and misuse; to date 
such a structured approach does not exist for substance use [47].
At the individual level there is no systematic approach in primary 
health care settings to follow up substance use apart from the use 
of the ‘Ferret’ program in most ACCHSs which deals with tobacco 
and alcohol as part of a person’s health check [47]. The need for a 
culturally appropriate alcohol and other drugs and mental health 
screening tool to encourage the early identification of Indigenous 
people at risk has been highlighted by several government 
reports [64]. The Indigenous Risk Impact Screen (IRIS) is a 13 item 
screening instrument for ‘alcohol and other drugs and mental 
health risk’ developed in response to this need. Schlesinger and 
colleagues (2007) validated IRIS as a brief screening instrument 
and recommended its use in general health-care settings because 
it is easily implemented, delivered quickly, is easily comprehended 
by clients and provides early identification of alcohol and other 
drug misuse, mental health risks, and enables a timely response 
to client needs [64]. The realisation of the potential of primary 
health care services to provide comprehensive substance misuse 
interventions (highlighted by Gray and colleagues (2004)) would 
facilitate a seamless and timely response to those individuals 
screened ‘at risk’.
At the community level projects tend to be small in scale with 
limited one-off funding [47]. This is highlighted by data from 1999-
2000, which showed that preventive programs made up only 21% 
of all intervention projects targeting Indigenous people. These 
programs received less than 10% of the allocated funding with 
almost half receiving only short-term, non-recurrent funding. 
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Secondary and tertiary intervention
The potential of primary health care services to provide 
comprehensive substance misuse interventions requires the 
availability of adequately trained staff with clearly defined roles 
in substance misuse intervention [47]. The potential capacity of 
primary health care services to provide ‘brief intervention’ for 
substance misuse is limited by the fact that other than acute care 
for injury and illness related to substance use, there are insufficient 
resources to provide intervention services.
h a r M  r e d u c t i o n
Currently harm reduction services, such as clean needle exchanges, 
are generally not integrated with other substance misuse services. 
Gray and colleagues (2004) note the potential for primary health care 
providers to provide a central networking role for substance misuse 
services, able to take referrals from those involved in services such as 
clean needle exchanges and other harm reduction strategies, and to 
provide referrals to other treatment or support services.
s u P P ly  c o n t r o l 
The Royal Australasian College of Physicians (RACP) recommends 
that illicit substances be redefined as primarily a health and social 
issue with funding commensurate with that of law enforcement. 
Citing research by Loxley and colleagues (2004) of the lack of 
evidence supporting supply reduction law enforcement strategies, 
the RACP recommends that supply control strategies undergo a 
comprehensive economic evaluation to determine their efficacy 
and to determine the nature and extent of any unintended 
negative consequences [56]. Similarly, the Northern Territory’s 
Select Committee on Substance Abuse in the Community (2007) 
found that there was an over-reliance on supply reduction and 
recommended that demand reduction and rehabilitation is 
supported while ensuring supply reduction strategies anticipate 
and prevent drug substitution [40]. 
Summary 
The use of illicit drugs among the Indigenous population is 
more than twice that of the non-Indigenous population; the 
trend shows illicit drug use increasing for all drug types. In 
remote areas the use of cannabis among Indigenous people 
is significantly greater than that of their urban counterparts.
The greater and increasing use of illicit drugs among the 
Indigenous population corresponds with greater and 
increasing health, social and economic impacts compared 
with the non-Indigenous population. The health impacts of 
illicit drug use include increases in morbidity for accidental 
poisoning involving illicit drugs, significant increases 
in HIV/AIDS and hepatitis C rates, higher rates of drug-
related mental/behavioural disorders, and the likelihood 
of significant rates of comorbidity and increases in suicide 
ideation and completion. Familial and community impacts 
include stressful family relationships, violence, harm to 
children and increases in crime and incarceration as well 
as significant economic costs borne by the individual, the 
family and the community.
Like the misuse of licit drugs among Indigenous people, the 
misuse of illicit drugs must be viewed against the backdrop 
of dispossession and oppression and the continuing legacy 
of exclusion and marginalisation of Indigenous people in 
Australia. This context explains the grave disparities in the 
social determinants of health that exist today for Indigenous 
people compared with non-Indigenous people. Indigenous 
people are significantly less likely to be educated, to be 
employed, to earn a level of income above subsistence 
and to live in adequate housing than their non-Indigenous 
counterparts. Such disadvantage fuels the stressors of 
life and perpetuates the dysfunction of families and 
communities; creating the conditions in which solace in 
drugs is sought.
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The National Drug Strategy and the National Drug Strategy 
Aboriginal and Torres Strait Islander Peoples’ Complementary 
Action Plan 2003-2009 seek to address illicit drug misuse 
among Indigenous people through harm minimisation; 
policies of demand reduction, harm reduction and supply 
reduction seek to improve the health, social, and economic 
outcomes for both the individual and the community. 
The key result areas consist of enhancing the capacity of 
Indigenous people to be involved in the promotion of their 
own wellbeing, whole-of-government responses to the 
reduction of drug-related harms, accessibility of services, 
holistic approaches, workforce initiatives, and sustainable 
partnerships between all stakeholders inclusive of 
Indigenous communities in research, monitoring, evaluation 
and dissemination of information. 
The enhancement of the capacity of Indigenous people to 
be involved in the promotion of their own wellbeing requires 
significant improvements in education and employment, 
but the need to address these underlying social factors 
has not resulted in a coordinated and holistic approach 
to substance misuse policy and therefore limits several 
of the key result areas. Similarly, the services available to 
Indigenous people show a lack of primary interventions for 
demand reduction, with a reliance on treatment rather than 
prevention. The unproven over-reliance on supply control 
strategies and the associated focus on law rather than health 
are not reflective of a whole-of-government and holistic 
response to the reduction of drug-related harms and may in 
fact add to the burden of harm for the user. Fundamental to 
all of the key result areas is an appropriate level of funding 
commensurate with need; underfunding and the nature of 
short-term non-recurrent funding undermines the ability 
to make tangible and lasting improvements in Indigenous 
health status including illicit drug misuse and its impacts.
Effective prevention and treatment (ensuring that we are not 
dealing with an endless flow of symptoms) rests primarily 
with equity in the social determinants of health. Evidence 
shows us the pervasive role disadvantage plays in the stark 
disparities in health status experienced by Indigenous 
people compared with non-Indigenous people; illicit drug 
misuse is intrinsically a part of this picture – it is perpetrated 
by disadvantage, thrives in disadvantage and compounds 
disadvantage. 
The challenge for governments to address the social inequity 
experienced by Indigenous people remains. The change of 
government in November 2007 has brought the opportunity 
for a new beginning in Indigenous affairs. The ‘Sorry Day’ 
speech of the Rudd Government on 13 February 2008, formally 
acknowledging and expressing sorrow for the wrongs of past 
policies in relation to the ‘Stolen Generations’, is an important 
first step of healing for Indigenous people and gives us reason 
as a nation to hope that the will of government is now such 
that ‘closing the gap’ is more than rhetoric.
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 Appendix 1
e x t e n t  o f  i l l i c i t  d r u g  u s e  i n 
au s t r a l i a
According to the 2007 National Drug Strategy Household Survey 
First Results (NDSHS) 1   [12]
•	 38% of Australians aged 14 years or older (more than 6 million 
people) had used an illicit drug at least once in their lifetime; 
13% (more than 2 million people) had used an illicit drug at 
least once in the previous 12 months
•	 cannabis was the most common illicit drug used – 33% of the 
population had ever used the drug and 9% had used in the 
previous year
•	 recent use of illicit drugs was most common among people 
aged 20-29 years of age (with almost one-third of males and 
one quarter of females using an illicit drug in the previous 
year), and for those aged 14–19 years (with around one-sixth 
of both males and females using an illicit drug in the previous 
year)According to the 2004 National Drug Strategy Household 
Survey 2   (detailed results of the 2007 NDSHS were not 
available at the time of writing) [41] the highest proportion of 
recent drug use was for people who were unemployed – more 
than one-third (32%) had used an illicit drug recently, more 
than twice the level for the total population (15%).
•	 recent illicit drug use was more common among the most 
socioeconomically disadvantaged (17%) than among people 
in other socioeconomic groups
•	 illicit drug use in the previous 12 months was more common 
for people living in remote and very remote regions (19%) than 
for those living in other regions
•	 for illicit drugs other than cannabis, use in the previous 12 
months was highest for people living in major cities (9%)
1  The NDSHS is conducted every three years. In 2007 the sample 
size was 23,356 persons aged 12 years and over. The analysis 
presented in almost all of the report relates to Australians aged 
14 years and older. 12 Australian Institute of Health and Welfare 
(2008) National drug strategy household survey: 2007 first 
results. (AIHW Catalogue no. PHE 98) Canberra: Australian 
Institute of Health and Welfare.
2  In 2004 the sample size was 29,445 persons aged 12 years and 
over. The analysis presented in almost all of the report relates to 
Australians aged 14 years and older. 41 Australian Institute of 
Health and Welfare (2005) 2004 National Drug strategy Household 
survey: detailed findings. (AiHw catalogue no. PHe 66) Canberra: 
Australian institute of Health and welfare.
Appendix 2 
s o u r c e s  a n d  l i M i tat i o n s  o f 
i n f o r M at i o n  o n  i l l i c i t  d r u g  u s e 
a M o n g  i n d i g e n o u s  P e o P l e
The three main sources of information about illicit drug use among 
Indigenous people are population surveys; the 2002 National 
Aboriginal and Torres Strait Islander Social Survey (NATSISS), the 
2004–2005 National Aboriginal and Torres Strait Islander Health 
Survey (NATSIHS) and the 2004 AND 2007 National Drug Strategy 
Household Surveys (NDSHS).
2002 NATSISS 
The 2002 NATSISS, a household survey conducted by the ABS, 
collected information from 9,400 Indigenous people aged 15 years 
or older [14]. Respondents lived in private dwellings and came 
from all states and territories. The ABS plans to conduct the survey 
every six years. 
Limitations of this survey include: 
•	 the lack of confidentiality in gathering information, resulting 
in a tendency for individuals to underestimate substance use 
(the unreliable nature of the illicit drug use data for people 
living in remote areas prevented its inclusion altogether) [65]
•	 it did not include people living in non-private dwellings 
(according to the 2001 census, 4% of the Indigenous 
population resides in non-private dwellings [13]) [65]
Given the exclusion of people living in remote areas (in 2001, 
around one-quarter of the Indigenous population [13]) and 
those living in non-private dwellings (likely to be the most 
socioeconomically disadvantaged group with the associated 
higher risks for substance use), the underestimation of illicit drug 
use among Indigenous people is likely to be significant [65].
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2004-2005 NATSIHS 
The 2004–2005 NATSIHS, also a household survey conducted by 
the ABS, collected information from 10,439 Indigenous people of all 
ages from remote and non-remote areas of Australia. Information 
on illicit substance use was collected from people aged 15 years or 
older living in non-remote areas using a voluntary self-completed 
form [66]. Thus, the limitations of the 2002 NATSISS also apply to 
the 2004–2005 NATSIHS.
2004 NDSHS 
The 2004 NDSHS, conducted by the AIHW, collected drug use 
information from 29,445 people aged 12 years or 14 years or older 
(as specified) residing in private households. Information on illicit 
drug use was presented for people aged 14 years or older. Only 463 
Indigenous respondents were included in this survey and therefore 
estimates must be interpreted with caution [11, 41].
2007 NDSHS: First results
The 2007 NDSHS, conducted by the AIHW, collected drug use 
information from 23,356 people aged 12 years or older or 14 years 
or older (as specified) residing in private households [12]. The 
analysis presented in almost all of the report relates to Australians 
aged 14 years and older. The 2007 NDSHS first results do not include 
information on the number of Indigenous respondents. Detailed 
findings were not available at the time of writing.
Evidence from other sources
As well as these population surveys, some information about illicit 
drug use among Indigenous people is available from a number of 
relatively small-scale studies and special reviews. Examples are the 
studies of cannabis use among Indigenous people living in remote 
communities in Arnhem Land [17], and the reviews undertaken 
by the Australasian Centre for Policing Research [18] and the 
Australian Institute of Criminology [19].
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The tutakalani
by Donna Lei Rioli
The art featured on this issue of the 
Australian Indigenous HealthReviews 
was painted by Donna Lei Rioli - a 
Western Australian Indigenous artist. Donna is a young Tiwi/ 
Nyoongar woman who enjoys painting because it enables her 
to express her Tiwi (father, Maurice Rioli) and Nyoongar (mother, 
Robyn Collard) heritage and she combines the two in a unique way.
